abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
1331: Tetanus & Diphtheria Toxoid IgG Antibodies Print View
Diphtheria Toxoid IgG Antibodies EIA  > .099  IU/mL 
Tetanus Toxoid IgG Antibodies EIA  > .150  IU/mL 

PRIMARY
1 Serum 2 (1) mL   Room Temperature - 7 Day(s)/Frozen - 2 Month(s)/Refrigerated - 14 Day(s)  
ALTERNATE

Used to evaluate Diphtheria and Tetanus immunization efficacy.

Reject Criteria:
Grossly hemolyzed, grossly lipemic, or grossly icteric specimens.
Setup Schedule
Tuesday, Thursday, Saturday

Reported (Analytical Time)
Same day

CPT Codes
86648, 86774

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Diphtheria Toxoid Abs: This test(s) was performed using a kit that has not been cleared or approved by the FDA. The analytical performance characteristics of this test have been determined by Specialty Laboratories. This test should not be used for diagnosis without confirmation by other medically established means. Tetanus Toxoid Abs: This test(s) was developed and its performance characteristics have been determined by Quest Diagnostics Nichols Institute, Valencia, CA. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test.






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database